Study Identifies Salivary microRNAs Linked to Long COVID and Periodontal Disease
Researchers analyzed salivary microRNAs in Long COVID patients and found 32 downregulated miRNAs in those with concurrent periodontal disease, suggesting shared inflammatory mechanisms. The study identified specific microRNAs that regulate inflammation pathways and directly target SARS-CoV-2 viral components. These findings suggest salivary microRNAs may serve as biomarkers and therapeutic targets for post-COVID oral complications.
A bioRxiv preprint study examined salivary microRNA profiles in convalescent individuals 3-6 months post-SARS-CoV-2 infection who developed Long COVID symptoms, particularly those with concurrent periodontal disease. Researchers identified 32 differentially expressed microRNAs—all downregulated—in COVID-19 positive/periodontal disease positive individuals compared to controls, with findings validated in a post-vaccination cohort. Functional analysis revealed these microRNAs regulate key inflammatory signaling pathways (Ras, MAPK, NF-κB) and directly target SARS-CoV-2 spike and nucleocapsid transcripts. Laboratory experiments demonstrated that three specific microRNAs (miR-30e-3p, miR-106-3p, miR-652-3p) suppressed inflammatory responses and reduced viral RNA abundance in infected epithelial cells. The research establishes a mechanistic link between periodontal inflammation and post-COVID pathology through dysregulated microRNA expression.
What's missing
The study's limitations regarding sample size, generalizability to diverse populations, and the clinical significance of the observed microRNA changes for patient outcomes are not detailed in the provided abstract. Additionally, the temporal relationship between microRNA dysregulation and symptom development in Long COVID remains unclear from this summary.
What different sources said
- bioRxivCenter
Salivary microRNA Profiling of Long COVID Subjects Reveals Host-Encoded Regulators of Inflammation and Viral Persistence
Related
Person dies from rare Murray Valley Encephalitis virus in Western Australia
A person has died after contracting Murray Valley Encephalitis, a rare mosquito-borne virus, while travelling in Western Australia's north, marking the first reported death from the virus in WA this year. The individual was likely exposed in early May in the West Kimberley region, about 2,000 kilometres north of Perth, before being transferred to a Perth hospital where they died. Health authorities are urging residents and tourists to protect themselves from mosquito bites as the region enters its peak tourism season, noting the virus can cause serious brain infection though complications remain rare.
Shigellosis outbreak in Wayanad rises to three confirmed cases; health officials launch investigation
A third student tested positive for shigellosis in Wayanad, Kerala, following an outbreak at Mar Baselios AUP School, bringing confirmed cases to three. The bacterial infection has caused symptoms in 473 people total, with 58 currently hospitalized, prompting health officials to investigate the source and implement stricter sanitation measures. The outbreak highlights concerns about water safety and food hygiene in the region, with authorities conducting well chlorination and inspections of food establishments.
Red-Light Therapy for Hair Loss: Clinical Evidence and Consumer Device Reviews
Wired published a 2026 guide reviewing red-light therapy devices for hair restoration, reporting that clinical studies suggest the treatment can increase blood circulation, reduce inflammation, and support hair follicle growth. Red-light therapy has emerged as an at-home alternative to traditional hair-loss treatments like topical remedies or surgical procedures. The guide matters because hair loss affects millions, and if clinically validated, at-home devices could democratize access to a non-invasive treatment option.